| Metric | Q3 2022 | Q2 2022 | Q3 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $398M | $322M | $269M | 23.6% | 47.8% |
| Op. Income | $52M | $38M | $67M | 35.6% | -23.0% |
| Gross Margin | 28.1% | 28.5% | 37.2% | -0.4pp | -9.1pp |
| Net Margin | 5.7% | 2.4% | 14.9% | 3.3pp | -9.1pp |
| EPS (Diluted) | $1.08 | $0.37 | $1.79 | 191.9% | -39.7% |
| Free Cash Flow | $22M | $22M | $59M | 0.1% | -62.1% |
| Item | Amount |
|---|---|
| REVENUE | $398M |
| Cost of Revenue | $286M |
| GROSS PROFIT | $112M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $40M |
| SG&A Expenses | $40M |
| Other Expenses | $20M |
| Operating Expenses | $60M |
| Cost & Expenses | $346M |
| OPERATING INCOME | $52M |
| Interest Income | $89.0K |
| Interest Expense | $20M |
| Other Income/Expenses | -$20M |
| INCOME BEFORE TAX | $32M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $23M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $23M |
| BOTTOM LINE NET INCOME | $23M |
| D&A | $17M |
| EBIT | $52M |
| EBITDA | $69M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $398M |
| Cost of Revenue | $286M |
| GROSS PROFIT | $112M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $40M |
| SG&A Expenses | $40M |
| Other Expenses | $20M |
| Operating Expenses | $60M |
| Cost & Expenses | $346M |
| OPERATING INCOME | $52M |
| Interest Income | $89.0K |
| Interest Expense | $20M |
| Other Income/Expenses | -$20M |
| INCOME BEFORE TAX | $32M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $23M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $23M |
| BOTTOM LINE NET INCOME | $23M |
| D&A | $17M |
| EBIT | $52M |
| EBITDA | $69M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $23M |
| Depreciation & Amortization | $17M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $3M |
| Other Non-Cash Items | $9M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $36M |
| Capital Expenditure | -$14M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $7M |
| NET CASH FROM INVESTING | -$6M |
| Net Debt Issuance | -$12M |
| Common Stock Repurchased | -$341.0K |
| Common Dividends Paid | -$9M |
| Other Financing Activities | -$325.0K |
| NET CASH FROM FINANCING | -$21M |
| FREE CASH FLOW | $22M |
| Net Change in Cash | $8M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $66M |
| Short-Term Investments | $0 |
| Net Receivables | $78M |
| Inventory | $6M |
| Other Current Assets | $39M |
| TOTAL CURRENT ASSETS | $205M |
| PP&E (Net) | $1.8B |
| Goodwill | $368M |
| Intangible Assets | $296M |
| Long-Term Investments | $0 |
| Tax Assets | $45M |
| Other Non-Current Assets | $175M |
| TOTAL NON-CURRENT ASSETS | $2.7B |
| TOTAL ASSETS | $2.9B |
| Account Payables | $49M |
| Short-Term Debt | $30M |
| Deferred Revenue | $14M |
| Other Current Liabilities | $6M |
| TOTAL CURRENT LIABILITIES | $468M |
| Long-Term Debt | $1.8B |
| Deferred Revenue NC | $41M |
| Deferred Tax Liabilities | $34M |
| Other Non-Current Liabilities | $116M |
| TOTAL NON-CURRENT LIABILITIES | $3.2B |
| TOTAL LIABILITIES | $3.6B |
| Common Stock | $826.0K |
| Additional Paid-In Capital | $507M |
| Retained Earnings | $1.8B |
| Treasury Stock | -$3.0B |
| Accum. Other Comp. Income | -$72M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$768M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$768M |
| TOTAL LIABILITIES & EQUITY | $2.9B |
| Total Debt | $3.2B |
| Net Debt | $3.1B |
